National Institute of Allergy and Infectious Diseases
NIAID Home Health & Science Research Funding Research News & Events Labs at NIAID About NIAID

Intracellular Parasites
 Chlamydial Pathogenesis
 Coxiella Pathogenesis
 Host-Parasite Interactions
 Salmonella Host-Cell Interaction
 Tularemia Pathogenesis
 Immunity to Pulmonary Pathogens


Laboratory of Intracellular Parasites

Catharine (Katy) Bosio, Ph.D.

Chief, Immunity to Pulmonary Pathogens Section

Description of Research Program

The focus of our research is to gain a better understanding of how aerosolized pathogens successfully infect and modulate the pulmonary environment to cause overt disease and death. Currently, our principal interest is the pathogenesis of aerosolized Francisella tularensis, the causative agent of pneumonic tularemia.

There are three primary areas of research ongoing in our laboratory: innate immunity to F. tularensis, vaccine development for pneumonic tularemia, and modulation of human cells by F. tularensis. We are particularly interested in modulation of primary antigen presenting cells (dendritic cells and macrophages) by F. tularensis and how this modulation allows the bacterium to initially evade host immune responses immediately following infection. We utilize both in vivo and in vitro models of disease to reveal specific mechanisms at play in both host and pathogen to gain a better understanding of the dynamic nature of this disease.

Research Group Members

Left to right: Katy Bosio, Debbie Crane, Norma Olivares Zavaleta, Jennifer Chase

 

 Immunity to Pulmonary Pathogens Section group members.

Selected Recent Publications

(View list in PubMed.)

Chase J, Celli C, Bosio CM. Direct and Indirect impairment of human dendritic cell function by virulent Francisella tularensis SchuS4.  2009. Infect Immun. 77:180-95.

C. M. Bosio, H. Bielfeldt-Ohmann and J.T. Belisle. Active suppresion of the pulmonary immune response by Francisella tularensis Schu4. J. Immunol. 2007 Apr 1; 178 (7): 4538-47.

X. Yang, B.J. Hinnebusch, T. Trunkle, C.M. Bosio, Z. Suo, M. Tighe, A. Harmsen, T. Becker, K. Crist, N. Walters, R. Avci and D. Pascual. Oral vaccination with salmonella simultaneously expressing Yersinia pestis F1 and V antigens protects against bubonic and pneumonic plague. J Immunol. 2007 Jan 15;178(2):1059-67.

K. Zaks, M. Jordon, A. Guth, K. Sellins, R. Kedl, A. Izzo, C. Bosio and S. Dow. Efficient immunization and cross-priming by vaccine adjuvants containing TLR3 or TLR9 agonists complexed to cationic liposomes. J Immunol. 2006 Jun 15;176(12):7335-45.

C.M. Bosio, A.Goodyear, and S. Dow. Early interaction of Yersinia pestis with APCs in the lung. J. Immunol. 2006. 175(10): 6750-6.

C.M. Bosio and Dow S. Francisella tularensis induces aberrant activation of pulmonary dendritic cells. J. Immunol. 2006. 175(10): 6792-801.

back to top

LICP Chief, Dr. Catharine Bosio

Contact Info

Catharine Bosio, Ph.D.
Phone: 406-363-9425
E-mail:
bosioc@niaid.nih.gov
Mail:
Rocky Mountain Laboratories
NIAID/NIH
903 South 4th St.
Hamilton, MT 59840

See Also

  • Division of Intramural Research (DIR)
  • Training Resources

  • NIH Logo

    The National Institute of Allergy and Infectious Diseases is a component of the National Institutes of Health, U.S. Department of Health and Human Services

    NIAID Logo

     
    Print Icon Print this page
    E-mail Icon E-mail this page
    Plug-ins and Viewers
    To open PDFs on this page, download and install the Adobe Acrobat Reader.
    LICP Chief, Dr. Catharine Bosio

    Contact Info

    Catharine Bosio, Ph.D.
    Phone: 406-363-9425
    E-mail:
    bosioc@niaid.nih.gov
    Mail:
    Rocky Mountain Laboratories
    NIAID/NIH
    903 South 4th St.
    Hamilton, MT 59840

    See Also

  • Division of Intramural Research (DIR)
  • Training Resources